Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
Polish version English version Language
enabled [disable] Abstract
Number of results

Results found: 1

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  "obesity pharmacotherapy
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

A review of medications used for treatment of obesity

100%
CZOPEK A., ZAGÓRSKA A., PAWŁOWSKI M.
Medicina Internacia Revuo
|
2016
|
vol. 27
|
issue 106
20-25
EN
Obesity, which occurs both in rich as well as developing countries, is a chronic disease that can cause many serious illnesses. It has become a global health problem, which affects onethird of adult population in the world. To induce weight loss, profound lifestyle modification is required. In the case, when lifestyle changes alone are insufficient, pharmacotherapy can be helpful. Most of anti-obesity drugs (e. g. fenfluramine, sibutramine, rimonabant), which have been approved for treatment of obesity, were subsequently withdrawn from the market due to their adverse effects. In this manuscript, a short overview of currently available anti-obesity drugs like orlistat, lorcaserin, liragutide as well as phentermine/topiramate and naltrexone/ bupropion combination, was presented. Herein we focus on efficiency, mechanism of action and possible side effects of anti-obesity drugs. Finally, it was emphasized that better understanding of mechanisms involved in appetite regulation could be useful for developing novel, more effective and better tolerated anti-obesity drugs.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.